Edition:
United States

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

15.24USD
25 May 2017
Change (% chg)

$-0.13 (-0.85%)
Prev Close
$15.37
Open
$15.54
Day's High
$15.54
Day's Low
$15.03
Volume
143,653
Avg. Vol
182,439
52-wk High
$25.11
52-wk Low
$9.68

NLNK.OQ

Chart for NLNK.OQ

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $449.20
Shares Outstanding(Mil.): 29.23
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 138.86 17.42
EPS (TTM): -2.84 -- --
ROI: -53.77 2.17 -5.45
ROE: -56.56 0.04 -4.73

BRIEF-Newlink Genetics reports first quarter 2017 financial results

* Newlink Genetics reports first quarter 2017 financial results and updates clinical trial guidance

May 04 2017

BRIEF-Newlink Genetics Q4 loss per share $0.46

* Qtrly total revenue $12.7 million versus. $7.7 million, qtrly loss per share $0.46 Source text for Eikon: Further company coverage:

Feb 28 2017

More From Around the Web

Competitors

Earnings vs. Estimates